Objective
Most older adults have multiple chronic diseases (multimorbidity) and multiple medications (polypharmacy).
However, multimorbid patients are often excluded from clinical trials and most guidelines address diseases in
isolation. Inappropriate drug prescription and poor drug compliance are common and contribute to up to 30% of
hospital admissions. OPERAM investigators developed STOPP/START criteria to detect inappropriate drug use,
both over- and underuse. Applying these criteria limits unnecessary polypharmacy and reduces underuse of indicated
medications, but it remains uncertain whether systematic pharmacotherapy optimisation can improve clinical
outcomes and reduce costs.We propose a multicentre randomised controlled trial to assess the impact of a userfriendly
software-assisted intervention to optimise pharmacotherapy and to enhance compliance in 1900 multimorbid
patients aged ≥75 years. Outcomes will include drug-related hospital admissions, health care utilisation, quality of life,
patient preferences and cost-effectiveness. We will also perform several network meta-analyses (NMA) to provide
new comparative evidence on the most effective and safest pharmacological and non-pharmacological interventions
to reduce common causes of preventable hospital admissions (e.g. falls, fractures, bleeding). Therapy optimisation in
the multimorbid elderly, enhanced compliance and discontinuation of less effective interventions have the potential
to improve clinical, quality of life and safety outcomes, while reducing costs. We will provide a structured method
with practical software solutions for optimal prescribing and new comparative evidence from NMAs for addressing
multimorbidity and polypharmacy by means of customised, patient-centred guidelines. OPERAM ultimately aims
at better healthcare delivery in primary and hospital care, based on effective, safe, personalised and cost-effective
interventions that can be applied to the rapidly growing older population in Europe.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences computer and information sciences software
- natural sciences computer and information sciences databases
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3.1.3. - Treating and managing disease
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
RIA - Research and Innovation action
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-PHC-2014-2015
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
3012 Bern
Switzerland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.